Related Experiment Video

Updated: May 11, 2026

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome
06:39

Use of Hematopoietic Stem Cell Transplantation to Assess the Origin of Myelodysplastic Syndrome

Published on: October 3, 2018

CD47 is expressed abnormally on hematopoietic cells in myelodysplastic syndrome

Huijuan Jiang1, Rong Fu, Huaquan Wang

  • 1Hematology Department, General Hospital, Tianjin Medical University, Tianjin, China.

Leukemia Research
|May 7, 2013
PubMed

Insights

In myelodysplastic syndromes (MDS), higher CD47 expression on leukemia stem cells (LSC) in high-risk patients may promote immune evasion. Lower CD47 on erythroblasts may correlate with anemia in MDS.

Area of Science:

  • Hematology
  • Immunology
  • Cancer Biology

Background:

  • Myelodysplastic syndromes (MDS) can progress to acute myeloid leukemia (AML).
  • The mechanisms of immune evasion by leukemia stem cells (LSC) in MDS are not fully understood.
  • CD47 is a molecule involved in immune evasion.

Purpose of the Study:

  • To investigate the role of CD47 expression on LSC and erythroblasts in MDS.
  • To explore the correlation between CD47 expression and disease risk and clinical features in MDS.

Main Methods:

  • Quantification of CD47 expression on LSC and erythroblasts in MDS patients.
  • Stratification of MDS patients based on IPSS/WPSS risk scores.
  • Correlation analysis between CD47 levels, risk scores, and peripheral blood counts (e.g., RBC).

Main Results:

  • CD47 expression was significantly higher on LSC from high-risk MDS patients compared to low-risk MDS and controls.
  • Increased proportion of CD34(+)CD38(-)CD47(+) cells was observed in high-risk MDS.
  • CD47 expression on erythroblasts showed a positive correlation with peripheral red blood cell (RBC) count.
  • Low CD47 expression on erythroblasts may be linked to anemia in MDS patients.

Conclusions:

  • Elevated CD47 on LSC in high-risk MDS may contribute to immune evasion by inhibiting phagocytosis.
  • CD47 expression on erythroblasts might play a role in the pathogenesis of anemia in MDS.

More Related Videos

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation12:05

Database-guided Flow-cytometry for Evaluation of Bone Marrow Myeloid Cell Maturation

Published on: November 3, 2018

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization08:13

Mitigation of Blood Borne Cell Attachment to Metal Implants through CD47-Derived Peptide Immobilization

Published on: December 3, 2020

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the daughter...
Regulation of Hematopoietic Stem Cells01:01

Regulation of Hematopoietic Stem Cells

All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...